The Market Herald Interview Discussing First-of-its-Kind Magnetic Imaging Technology
We recently announced that our MagSense® diagnostic technology has the potential to target prostate cancer tumors, making this the second cancer type the…
Fear and Greed Podcast Discussing Precise Imaging Solutions to Detect Cancers
Our Chairman and CEO Bob Proulx was a recent guest at the Fear and Greed podcast, discussing our pursuit of better, more precise imaging solutions to detect…
2022 Switzer Small & Micro Cap Conference Presentation
Imagion Bio CEO, Robert Proulx, presents company information to investors at the 2022 Switzer Small & Micro Cap Conference in September. Video Transcript:…
Q&A Session at 2022 Annual General Meeting
Imagion Biosystems recording of the Q&A session at the 2022 Annual General Meeting. Imagion Biosystems' board of directors answer questions from…
Presentation Visuals from 25th May 2022 Annual General Meeting
The presentation visuals from the 25th May 2022 Annual General Meeting are now available. You can find the 2022 AGM Investor Presentation here. …
Health Industry Hub Interview
Bob Proulx sat down with Rozalina Sarkezians, Managing Director & Founder of Health Industry Hub, for a chat about Imagion Biosystem’s work developing our…
Ticker News Interview - Breast Cancer Clinical Trial Update
Bob Proulx discusses updates on the first-in-human MagSense® HER2 breast cancer clinical trial with TickerTV - trial is progressing positively. …
Imagion Bio at The Edison Open House: Global Healthcare 2022
Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging…
Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting
As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems' President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as…
Q&A with Chief Development Officer Yalia Jayalakshmi, Ph.D.
In this video, Chief Development Officer Yalia Jayalakshmi, Ph.D. explains why she joined Imagion Biosystems, the urgency of the company's mission, and the…
